• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Designer vascular graft takes hold

Article

University of Pittsburgh researchers found preclinical success with an artificial blood vessel engineered from muscle-derived stem cells and a biodegradable polymer. Results could benefit the treatment of heart and kidney diseases, which need new sources of blood vessels for vascular grafts.

University of Pittsburgh researchers found preclinical success with an artificial blood vessel engineered from muscle-derived stem cells and a biodegradable polymer. Results could benefit the treatment of heart and kidney diseases, which need new sources of blood vessels for vascular grafts.

According to Alejandro Nieponice, Ph.D., and colleagues, saphenous vein coronary artery bypass grafts often fail, and arterial grafts, while less prone to become obstructed, are in limited supply as many patients require multiple grafts. Thus, a need exists for a small-caliber arterial substitute for revascularization procedures.

Results of the study, presented at the 2007 Tissue Engineering and Regenerative Medicine International Society meeting, showed that cell-seeded grafts in rats had significantly less blockage than controls and exhibited extensive remodeling consistent with a mature artery. Researchers said that grafts made from a patient's own stem cells could be ready almost immediately, which "suggests that we could make these available 'off-the-shelf,' an essential element for clinical translation."

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.